XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS' EQUITY (Tables)
 6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost on Net Earnings
The Company’s results for the three and six months ended June 30, 2025 and 2024 reflected the following stock-based compensation cost, and such compensation cost had the following effects on net earnings:

Increase/(Decrease) for theIncrease/(Decrease) for the
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Cost of sales$536 $425 $974 $825 
Operating expenses5,302 3,461 8,674 7,811 
Net earnings(4,577)(2,974)(7,506)(6,627)
Schedule of Stock Option Activity
Option activity for the six months ended June 30, 2025 and 2024 is summarized below:
For the Six Months Ended June 30, 2025Shares (000s)Weighted
Average
Exercise
Price		Aggregate
Intrinsic
Value		Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 2024962 $114.81 $46,346 
Granted51 159.18 
Exercised(68)91.48 
Forfeited— — 
Canceled— — 
Outstanding as of June 30, 2025945 $118.88 $38,084 5.6
Exercisable as of June 30, 2025638 $106.87 $33,375 4.4
For the Six Months Ended June 30, 2024Shares (000s)Weighted
Average
Exercise
Price		Aggregate
Intrinsic
Value		Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 20231,078 $104.38 $47,889 
Granted113 143.43 
Exercised(137)70.75 
Forfeited(2)137.06 
Canceled— — 
Outstanding as of June 30, 20241,052 $112.90 $43,199 6.0
Exercisable as of June 30, 2024687 $98.31 $38,241 4.7
Schedule of Other Information Pertaining to Stock Option Activity
Other information pertaining to option activity during the three and six months ended June 30, 2025 and 2024 is as follows:

 Three Months Ended
June 30,		Six Months Ended
June 30,
 2025202420252024
Weighted-average fair value of options granted$— $— $48.86 $44.52 
Total intrinsic value of stock options exercised ($000s)$3,370 $944 $4,759 $11,321 
Schedule of Non-vested Restricted Stock Activity
Non-vested restricted stock activity for the six months ended June 30, 2025 and 2024 is summarized below:
Six Months Ended June 30,
20252024
Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 31122 $141.62 116 $133.06 
Granted54 159.14 37 143.78 
Vested(30)137.83 (32)119.11 
Forfeited(1)145.96 (2)132.81 
Non-vested balance as of June 30145 $148.91 119 $140.14 
Schedule of Non-vested Performance Share Activity
Non-vested performance share activity for the six months ended June 30, 2025 and 2024 is summarized below:

Six Months Ended June 30,
20252024
Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 3179 $150.73 76 $135.25 
Granted50 147.96 47 152.28
Vested(44)130.29 (44)106.57
Forfeited(4)152.69 — —
Non-vested balance as of June 3081 $160.14 79 $150.73